OR8B2
gene geneOn this page
Summary
OR8B2 (olfactory receptor family 8 subfamily B member 2, HGNC:8471) is a protein-coding gene on chromosome 11q24.2, encoding Olfactory receptor 8B2 (Q96RD0). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 26595 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 96 total
- MANE Select transcript:
NM_001005468
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8471 |
| Approved symbol | OR8B2 |
| Name | olfactory receptor family 8 subfamily B member 2 |
| Location | 11q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000284680 |
| Ensembl biotype | protein_coding |
| Entrez | 26595 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000641451
RefSeq mRNA: 1 — MANE Select: NM_001005468
NM_001005468
CCDS: CCDS31708
Canonical transcript exons
ENST00000641451 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003813023 | 124382394 | 124383360 |
| ENSE00003813829 | 124384374 | 124384499 |
Expression profiles
Bgee: expression breadth tissue_specific, 7 present calls, max score 75.38.
Top tissues by expression
234 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.38 | silver quality |
| left testis | UBERON:0004533 | 46.48 | gold quality |
| testis | UBERON:0000473 | 45.55 | gold quality |
| right testis | UBERON:0004534 | 45.49 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| sperm | CL:0000019 | 42.39 | silver quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 40.27 | gold quality |
| jejunum | UBERON:0002115 | 40.18 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.06 | gold quality |
| oviduct epithelium | UBERON:0004804 | 40.03 | gold quality |
| mammary duct | UBERON:0001765 | 39.98 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 39.95 | gold quality |
| deltoid | UBERON:0001476 | 39.83 | gold quality |
| saphenous vein | UBERON:0007318 | 39.83 | gold quality |
| parotid gland | UBERON:0001831 | 39.81 | gold quality |
| oocyte | CL:0000023 | 39.80 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.81 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or8b3b | ENSMUSG00000046150 |
| mus_musculus | Or8b3 | ENSMUSG00000049098 |
| rattus_norvegicus | Or8b3 | ENSRNOG00000062775 |
| rattus_norvegicus | Or8b3c | ENSRNOG00000068253 |
Paralogs (96): OR5C1 (ENSG00000148215), OR5F1 (ENSG00000149133), OR8K1 (ENSG00000150261), OR5M9 (ENSG00000150269), OR14K1 (ENSG00000153230), OR8J3 (ENSG00000167822), OR5I1 (ENSG00000167825), OR5AU1 (ENSG00000169327), OR9K2 (ENSG00000170605), OR8B12 (ENSG00000170953), OR10H3 (ENSG00000171936), OR8I2 (ENSG00000172154), OR8U1 (ENSG00000172199), OR10V1 (ENSG00000172289), OR5A1 (ENSG00000172320), OR5A2 (ENSG00000172324), OR5B12 (ENSG00000172362), OR5B2 (ENSG00000172365), OR9I1 (ENSG00000172377), OR9G4 (ENSG00000172457), OR5AR1 (ENSG00000172459), OR5AP2 (ENSG00000172464), OR8J1 (ENSG00000172487), OR5B3 (ENSG00000172769), OR10W1 (ENSG00000172772), OR5M3 (ENSG00000174937), OR5J2 (ENSG00000174957), OR10H4 (ENSG00000176231), OR5AN1 (ENSG00000176495), OR14C36 (ENSG00000177174), OR6B3 (ENSG00000178586), OR10Q1 (ENSG00000180475), OR8G2P (ENSG00000181214), OR5AK2 (ENSG00000181273), OR5AK3P (ENSG00000181282), OR5M8 (ENSG00000181371), OR8D4 (ENSG00000181518), OR8H1 (ENSG00000181693), OR8K5 (ENSG00000181752), OR8H3 (ENSG00000181761)
Protein
Protein identifiers
Olfactory receptor 8B2 — Q96RD0 (reviewed: Q96RD0)
Alternative names: Olfactory receptor OR11-309
All UniProt accessions (2): Q96RD0, A0A126GVQ4
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001005468* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (22 total): topological domain 8, transmembrane region 7, sequence variant 4, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96RD0-F1 | 89.41 | 0.63 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 16 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, chr11q24, GOMF_ODORANT_BINDING, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY
GO Biological Process (4): G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), signal transduction (GO:0007165), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), odorant binding (GO:0005549)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
76 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR8B2 | NCOA6 | Q14686 | 368 |
| OR8B2 | NOVA1 | P51513 | 326 |
| OR8B2 | OR51Q1 | Q8NH59 | 263 |
| OR8B2 | ADPRS | Q9NX46 | 220 |
| OR8B2 | KCNF1 | Q9H3M0 | 201 |
| OR8B2 | RPS4Y1 | P22090 | 197 |
| OR8B2 | LHX5 | Q9H2C1 | 196 |
| OR8B2 | FEZF1 | A0PJY2 | 185 |
| OR8B2 | KCNG1 | Q9UIX4 | 181 |
| OR8B2 | PTPN5 | P54829 | 169 |
| OR8B2 | HOMER3 | Q9NSC5 | 165 |
| OR8B2 | HEMGN | Q9BXL5 | 164 |
| OR8B2 | NNAT | Q16517 | 162 |
| OR8B2 | OR52D1 | Q9H346 | 160 |
| OR8B2 | ELP5 | Q8TE02 | 155 |
IntAct
0 interactions, top by confidence:
BioGRID (1): ZNF24 (Co-fractionation)
ESM2 similar proteins: A6NCV1, A6NF89, A6NJZ3, A6NL08, A6NM76, O95221, P0C7N1, P0C7N5, P37070, P37071, P37072, Q15617, Q60886, Q6IEU7, Q8N127, Q8NGE1, Q8NGG0, Q8NGG8, Q8NGP8, Q8NGP9, Q8NGR8, Q8NGS9, Q8NGT0, Q8NGT1, Q8NGX3, Q8NH01, Q8NH10, Q8NH51, Q8NH69, Q8VEW5, Q8VF65, Q8VF66, Q8VF76, Q8VFD0, Q8VFD3, Q8VFK2, Q8VG02, Q8VG03, Q8VG04, Q8VG07
Diamond homologs: A6NDH6, A6NET4, A6NHG9, A6NKK0, A6NL26, A6NMS3, O95221, P0C626, P0C628, P0C7N1, P0C7N5, P0DMU2, P0DN80, P34985, P37068, P37070, P37071, P37072, Q13606, Q15617, Q15620, Q60880, Q60882, Q60884, Q60886, Q60893, Q60894, Q6UXT6, Q7TS48, Q8N127, Q8N146, Q8N162, Q8NG75, Q8NG78, Q8NGC0, Q8NGF4, Q8NGF7, Q8NGG0, Q8NGG1, Q8NGG2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
96 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 87 |
| Likely benign | 9 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
245 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:124382587:C:T | acceptor_gain | 0.8500 |
| 11:124382587:C:CT | acceptor_gain | 0.8300 |
| 11:124383022:C:CT | acceptor_gain | 0.7700 |
| 11:124382588:A:T | acceptor_gain | 0.7000 |
| 11:124382475:C:CC | acceptor_gain | 0.6900 |
| 11:124382471:CAAA:C | acceptor_gain | 0.6500 |
| 11:124382504:CACAT:C | acceptor_gain | 0.6400 |
| 11:124382673:C:CC | acceptor_gain | 0.6200 |
| 11:124383225:A:AC | donor_gain | 0.6000 |
| 11:124383226:C:CC | donor_gain | 0.6000 |
| 11:124382511:G:GC | acceptor_gain | 0.5900 |
| 11:124383221:GCCTA:G | donor_loss | 0.5900 |
| 11:124383222:CCTA:C | donor_loss | 0.5900 |
| 11:124383223:CTA:C | donor_loss | 0.5900 |
| 11:124383224:TACCA:T | donor_loss | 0.5900 |
| 11:124383225:ACCA:A | donor_loss | 0.5900 |
| 11:124383023:G:T | acceptor_gain | 0.5800 |
| 11:124382551:C:CT | acceptor_gain | 0.5600 |
| 11:124383226:CCATG:C | donor_gain | 0.5600 |
| 11:124383111:G:GC | acceptor_gain | 0.5500 |
| 11:124382670:ATGCT:A | acceptor_loss | 0.5400 |
| 11:124382671:TG:T | acceptor_gain | 0.5400 |
| 11:124382671:TGCT:T | acceptor_loss | 0.5400 |
| 11:124382672:GC:G | acceptor_loss | 0.5400 |
| 11:124382673:C:CG | acceptor_loss | 0.5400 |
| 11:124382674:T:G | acceptor_loss | 0.5400 |
| 11:124382508:T:TC | acceptor_gain | 0.5200 |
| 11:124383163:A:AC | donor_gain | 0.5200 |
| 11:124383225:AC:A | donor_gain | 0.5200 |
| 11:124383226:CC:C | donor_gain | 0.5200 |
AlphaMissense
2072 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:124382840:G:C | F168L | 0.812 |
| 11:124382840:G:T | F168L | 0.812 |
| 11:124382842:A:G | F168L | 0.812 |
| 11:124383308:A:C | F12L | 0.801 |
| 11:124383308:A:T | F12L | 0.801 |
| 11:124383310:A:G | F12L | 0.801 |
| 11:124382630:G:C | F238L | 0.707 |
| 11:124382630:G:T | F238L | 0.707 |
| 11:124382632:A:G | F238L | 0.707 |
| 11:124382711:A:C | S211R | 0.681 |
| 11:124382711:A:T | S211R | 0.681 |
| 11:124382713:T:G | S211R | 0.681 |
| 11:124382588:A:C | F252L | 0.677 |
| 11:124382588:A:T | F252L | 0.677 |
| 11:124382590:A:G | F252L | 0.677 |
| 11:124382591:A:C | F251L | 0.653 |
| 11:124382591:A:T | F251L | 0.653 |
| 11:124382593:A:G | F251L | 0.653 |
| 11:124383251:A:C | F31L | 0.611 |
| 11:124383251:A:T | F31L | 0.611 |
| 11:124383253:A:G | F31L | 0.611 |
| 11:124382573:G:C | F257L | 0.601 |
| 11:124382573:G:T | F257L | 0.601 |
| 11:124382575:A:G | F257L | 0.601 |
| 11:124382636:T:A | K236N | 0.594 |
| 11:124382636:T:G | K236N | 0.594 |
| 11:124382516:G:C | F276L | 0.586 |
| 11:124382516:G:T | F276L | 0.586 |
| 11:124382518:A:G | F276L | 0.586 |
| 11:124383038:A:C | F102L | 0.585 |
dbSNP variants (sampled 300 via entrez): RS1000166192 (11:124397220 G>A,C), RS1000715058 (11:124389855 T>C), RS1000821067 (11:124382894 T>C), RS1000863538 (11:124389111 A>G), RS1000890054 (11:124384583 A>C), RS1001490222 (11:124394702 G>A), RS1001574328 (11:124386242 A>T), RS1001921269 (11:124383213 C>A,G,T), RS1002512997 (11:124393849 C>A), RS1002616536 (11:124394852 TTA>T), RS1003056885 (11:124399240 C>T), RS1003107428 (11:124386585 A>C), RS1003108702 (11:124393575 AC>A), RS1003801774 (11:124398098 C>G,T), RS1003827273 (11:124391098 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Endosulfan | decreases expression | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.